183 related articles for article (PubMed ID: 25354682)
1. Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors.
Lai YH; Lin CC; Chen SH; Tai CK
Gene Ther; 2015 Feb; 22(2):155-62. PubMed ID: 25354682
[TBL] [Abstract][Full Text] [Related]
2. Replicating retroviral vectors for oncolytic virotherapy of experimental hepatocellular carcinoma.
Lu YC; Chen YJ; Yu YR; Lai YH; Cheng JC; Li YF; Shen CH; Tai CK
Oncol Rep; 2012 Jul; 28(1):21-6. PubMed ID: 22552490
[TBL] [Abstract][Full Text] [Related]
3. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Cancer Gene Ther; 2007 Mar; 14(3):279-86. PubMed ID: 17218950
[TBL] [Abstract][Full Text] [Related]
4. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter.
Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J
Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 142-3p attenuates spread of replicating retroviral vector in hematopoietic lineage-derived cells while maintaining an antiviral immune response.
Lin AH; Timberlake N; Logg CR; Liu Y; Kamijima S; Diago O; Wong K; Gammon DK; Ostertag D; Hacke K; Yang EC; Gruber H; Kasahara N; Jolly DJ
Hum Gene Ther; 2014 Aug; 25(8):759-71. PubMed ID: 24825189
[TBL] [Abstract][Full Text] [Related]
6. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
7. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study.
Li W; Li DM; Chen K; Chen Z; Zong Y; Yin H; Xu ZK; Zhu Y; Gong FR; Tao M
BMC Cancer; 2012 Nov; 12():547. PubMed ID: 23173703
[TBL] [Abstract][Full Text] [Related]
8. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Efficacy of Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors for Human Ovarian Cancer.
Isoda L; Sonoda-Fukuda E; Fujino H; Takarada T; Hasegawa K; Kasahara N; Kubo S
Anticancer Res; 2023 Dec; 43(12):5311-5317. PubMed ID: 38030176
[TBL] [Abstract][Full Text] [Related]
10. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.
Kanai F; Lan KH; Shiratori Y; Tanaka T; Ohashi M; Okudaira T; Yoshida Y; Wakimoto H; Hamada H; Nakabayashi H; Tamaoki T; Omata M
Cancer Res; 1997 Feb; 57(3):461-5. PubMed ID: 9012474
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
12. Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model.
Chen SH; Sun JM; Chen BM; Lin SC; Chang HF; Collins S; Chang D; Wu SF; Lu YC; Wang W; Chen TC; Kasahara N; Wang HE; Tai CK
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093290
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
Cao G; Kuriyama S; Gao J; Nakatani T; Chen Q; Yoshiji H; Zhao L; Kojima H; Dong Y; Fukui H; Hou J
Eur J Cancer; 2001 Jan; 37(1):140-7. PubMed ID: 11165141
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional targeted gene therapy for hepatocellular carcinoma by adenovirus vector.
Kanai F
Mol Biotechnol; 2001 Jul; 18(3):243-50. PubMed ID: 11503518
[TBL] [Abstract][Full Text] [Related]
15. A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cells.
Cao G; Kuriyama S; Tsujinoue H; Chen Q; Mitoro A; Qi Z
Int J Cancer; 2000 Jul; 87(2):247-52. PubMed ID: 10861483
[TBL] [Abstract][Full Text] [Related]
16. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J
Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059
[TBL] [Abstract][Full Text] [Related]
17. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
18. Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors.
Metzl C; Mischek D; Salmons B; Günzburg WH; Renner M; Portsmouth D
J Virol; 2006 Jul; 80(14):7070-8. PubMed ID: 16809312
[TBL] [Abstract][Full Text] [Related]
19. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene.
Mohr L; Shankara S; Yoon SK; Krohne TU; Geissler M; Roberts B; Blum HE; Wands JR
Hepatology; 2000 Mar; 31(3):606-14. PubMed ID: 10706550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
